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Abstract
Integumentary wounds in mammalian fetuses heal without scar; this scarless wound healing is intrinsic to fetal tissues and is
notable for absence of the contraction seen in postnatal (adult) wounds. The precise molecular signals determining the
scarless phenotype remain unclear. We have previously reported that the eta subunit of the chaperonin containing T-
complex polypeptide (CCT-eta) is specifically reduced in healing fetal wounds in a rabbit model. In this study, we examine
the role of CCT-eta in fibroblast motility and contractility, properties essential to wound healing and scar formation. We
demonstrate that CCT-eta (but not CCT-beta) is underexpressed in fetal fibroblasts compared to adult fibroblasts. An in vitro
wound healing assay demonstrated that adult fibroblasts showed increased cell migration in response to epidermal growth
factor (EGF) and platelet derived growth factor (PDGF) stimulation, whereas fetal fibroblasts were unresponsive.
Downregulation of CCT-eta in adult fibroblasts with short inhibitory RNA (siRNA) reduced cellular motility, both basal and
growth factor-induced; in contrast, siRNA against CCT-beta had no such effect. Adult fibroblasts were more inherently
contractile than fetal fibroblasts by cellular traction force microscopy; this contractility was increased by treatment with EGF
and PDGF. CCT-eta siRNA inhibited the PDGF-induction of adult fibroblast contractility, whereas CCT-beta siRNA had no
such effect. In each of these instances, the effect of downregulating CCT-eta was to modulate the behavior of adult
fibroblasts so as to more closely approximate the characteristics of fetal fibroblasts. We next examined the effect of CCT-eta
modulation on alpha-smooth muscle actin (a-SMA) expression, a gene product well known to play a critical role in adult
wound healing. Fetal fibroblasts were found to constitutively express less a-SMA than adult cells. Reduction of CCT-eta with
siRNA had minimal effect on cellular beta-actin but markedly decreased a-SMA; in contrast, reduction of CCT-beta had
minimal effect on either actin isoform. Direct inhibition of a-SMA with siRNA reduced both basal and growth factor-induced
fibroblast motility. These results indicate that CCT-eta is a specific regulator of fibroblast motility and contractility and may
be a key determinant of the scarless wound healing phenotype by means of its specific regulation of a-SMA expression.
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Introduction
Adult mammalian tissues respond to injury by healing with scar
formation [1,2]; in contrast, mammalian fetuses demonstrate an
ability to heal without scar, a process that has been likened to
regeneration [3,4]. Although scar formation allows for the rapid
sealing of an injured area, it can frequently prove the source of
persistent pathology in the organism, eg. restricting movement,
narrowing viscera etc. At the phenotypic level adult and fetal
wound healing differ in multiple important respects: adult wound
healing is marked by a prominent initial acute inflammatory
response, which is absent in fetal wound healing, and fetal wound
healing displays no accumulation of intermediary granulation
tissue as found in healing adult wounds [4]. Most importantly for
this study, healing adult wounds are characterized by a marked
contraction of the wound substance, thought to be mediated by
tissue fibroblasts (and their cellular derivatives, myofibroblasts),
whereas in fetal wounds no such contraction occurs. It has been
suggested that fibroblasts/ myofibroblasts effect wound contrac-
tion either by acting together as a contractile unit, or more likely
by acting individually to apply traction to a wound in the process
of cell locomotion [5,6,7].
Multiple studies have sought to identify the key molecular
agents responsible for scarless wound healing, and have examined
the roles of various growth factors, cytokines, extracellular matrix
(ECM) proteins [8], chaperonins and homeobox genes among
others [2,8,9,10,11,12,13,14,15]. Despite observed differences in
expression, however, the critical molecular mechanisms by which
scarless fetal wound healing distinguishes itself from scirrhous
wound healing remain unclear. The recapitulation of a fetal
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pattern of wound healing in adult tissues would be of enormous
clinical significance, as it would allow for mitigation of scar
formation and diminish the attendant morbidity.
We have previously investigated gene expression in healing fetal
wounds in vivo with multiple expressomic techniques, including
differential display [11], PCR suppression subtraction hybridization
[12] and fetal wound specific microarrays (Kathju et al., manuscript
in preparation). These investigations have allowed us to compare
the fetal (and adult) wound expressomes without any preconcep-
tions as to which gene products may be important. Multiple
candidate genes have been found to be differentially and specifically
regulated in healing fetal wounds; this report focuses on the eta
subunit of the chaperonin containing T-complex polypeptide
(CCT-eta), which was noted to be specifically underexpressed in
fetal wounds by differential display RT-PCR [11].
The CCT molecule is the major cytosolic chaperonin in
eukaryotes and has been estimated to interact with up to 15% of
all cellular proteins. The structure of the CCT holoenzyme is
unique among chaperonins, consisting of a pair of identical rings;
each ring is composed of eight different 60-kDa subunits: alpha,
beta, gamma, delta, epsilon, eta, theta and zeta [16] which are
coded by eight different genes [17,18,19]. CCT’s role as a
chaperonin has been best elucidated in its interactions with the
cytoskeletal proteins actin and tubulin [20], but it has also been
found to assist in the folding of multiple other proteins, including
cyclin E, myosin, transducin and Von Hippel Lindau tumor
suppressor among others. Alteration of CCT expression thus has
the potential to impose pleiotropic secondary effects on cells.
The majority of studies on CCT function have thus far focused
on the holoenzyme, however, an increasing body of evidence
suggests that the individual subunits of CCT have an independent
function and significance. Roobol and Carden have found that not
all CCT subunits co-localize identically within cells, suggesting
individual subunit functionalization [21]. Genetic studies have
identified several discrete CCT subunit genes as the loci for
mutations resulting in neurological defects: a 143 bp deletion in
CCT-gamma causes the no tectal neuron phenotype in zebrafish
[22]; a missense mutation in CCT-delta causes the mutilated foot
phenotype in rats [23]; a missense mutation in CCT-epsilon is
responsible for mutilating sensory neuropathy with spastic
paraplegia in humans [24]. Individual subunits have also been
identified as the biological partners of various proteins; yeast two-
hybrid analysis has identified the EBNA-3 nuclear protein from
Epstein-Barr virus as binding to CCT-epsilon [25], and signifi-
cantly the CCT-eta subunit has been found to serve as a co-factor
for the soluble guanylyl cyclase [26].
CCT is ubiquitously expressed in all eukaryotic tissues thus far
examined, and Kubota et al. describe that in mouse tissues all
CCT subunits appear to be coordinately regulated [27]. Cyrne
et al. [28] note that the CCT-eta and -gamma mRNAs are co-
regulated during ciliary biogenesis and sexual reproduction in
Tetrahymena. However, in other systems no such co-regulation is
apparent. Himmelspach et al. [29] working in a plant system, find
a light dependent reduction of CCT-epsilon but not CCT-alpha.
Few reports examine all eight major CCT subunits.
The only examination of CCT function in wound healing thus
far has centered on CCT-eta. Previous studies from our laboratory
have shown the specific reduction of CCT-eta mRNA in the
healing fetal wound mileu [11] and subsequently we have also
shown that no other CCT subunit shares this distinct pattern of
gene regulation [14]. In contrast, Koulikovska et al. [30] have
shown that increased expression of CCT-eta correlated with the
increased expression of alpha smooth muscle actin (a-SMA) in an
adult rabbit model of corneal wounding. The substantial decrease
of CCT-eta in a fetal wound healing mileu (in contrast to adult
wounds) lead us to hypothesize that CCT-eta might be a critical
determinant of the distinct behavior of these two phenotypes and
that the regulation of CCT-eta expression might modulate the
healing response of adult wounds.
We have focused our efforts on what effects specific modulation
of CCT-eta levels might have on fibroblast physiology. Since
fibroblasts are the ultimate effectors of scar deposition and
contraction, and since wound healing (in adults) requires that
they migrate into a wound bed and contract the wound substance,
we have directed our studies to the examination of fibroblast
motility and contractility and the role of CCT subunits therein.
We first demonstrate that fetal fibroblasts express substantially less
CCT-eta subunit compared to adult fibroblasts, and that they have
inherently distinct characteristics of cellular locomotion and
traction. Most particularly, we employ siRNAs directed against
two discrete subunits (CCT-eta and CCT-beta) to demonstrate
that only downregulation of the former has marked effects on the
motility and contractility of adult fibroblasts, in each case shifting
the adult fibroblast profile towards a more fetal-like state.
We next examined expression of cellular actin, long understood
as the major cytoskeletal element in cellular locomotion and
traction, and known to be a major substrate of the CCT
holoenzyme. Fibroblasts are known to express two actin isoforms
(namely b- and c- actin) which are similarly expressed in all
eukaryotic cell types. However, under certain conditions fibro-
blasts may also express the alpha-smooth muscle isoform of actin
(a-SMA), eg. when stimulated by serum in tissue culture or when
stimulated during adult wound healing in vivo to function as
‘‘myofibroblasts,’’ the derivative cell type most closely associated
with wound contraction and scar formation. The presence of a-
SMA has also been found to closely correlate with the appearance
of scar formation even in fetal tissues that have already
transitioned to the adult scar-forming phenotype in late gestation,
whereas a-SMA is largely absent from earlier scarlessly healing
fetal wounds [31,32]. Thus, a-SMA expression appears to be an
important differentiating feature between scarring and scarless
wounds, and offers a potential mechanistic connection between
CCT function, fibroblast physiology, and scar contracture.
We now report that fetal fibroblasts express less constitutive a-
SMA than adult cells, and that reduction of CCT-eta markedly
diminishes a-SMA protein levels, whereas reduction of CCT-beta
has no such effect. Direct reduction of a-SMA leads to a similar
decrease in both basal and growth-factor induced motility as seen
with CCT-eta depletion, again causing adult fibroblasts to mimic a
more fetal pattern of behavior.
Materials and Methods
Materials
Human epidermal growth factor (EGF) was obtained from
Collaborative Biomedical Products (Bedford, MA). Human
platelet derived growth factor (PDGF-BB) was purchased from
R&D Systems (Minneapolis, MN). Antibodies against CCT-eta
(cat # MCA2179) and CCT-beta (cat # MCA2275) were
purchased from Serotec Inc. (Raleigh, NC). Antibody against a-
SMA was purchased from Sigma Chemical Corp. (St Louis, MO).
Antibody against GAPDH (cat # ab8245) was purchased from
Abcam, Inc. (Cambridge, MA). RPMI-1640 medium, Trypsin-
EDTA, OptiMEM and Lipofectamine 2000 were obtained from
Invitrogen Corp. (Carlsbad, California). Antibiotic and antimy-
cotic solution was purchased from Sigma Chemical Corp. Fetal
bovine serum was purchased from Gemini Bio-Products (West
Sacramento, CA).
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Animal Protocol and Nucleic Acid Isolation
All animal protocols were reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC) of the
Allegheny General Hospital, Pittsburgh, PA and followed
guidelines set forth in the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. The tissue harvesting
protocol for our New Zealand white rabbits, RNA isolation/
storage from fetal and adult tissues was performed as previously
described [11,12]. The quality and quantity of total RNA
extracted from tissues and fibroblasts were determined by
measuring the OD 260/OD 280 ratio using the ND-1000
spectrophotometer (Nanodrop Technologies Inc., Wilmington,
DE) and by capillary electrophoresis with the Agilent 2100
BioAnalyzer (Agilent Technologies Inc., Palo Alto, CA).
Dermal Fibroblast Culture
New Zealand white rabbits were anesthetized and freshly
excised skin specimens (around 1 sq cm) from adult and fetal
rabbits (gestational age 21 days) were minced into small pieces
within 30 minutes after dissection. These tissue pieces were
washed exclusively in PBS containing 1% antibiotic/antimycotic
solution (Sigma, St Louis, MO) and then placed in the RPMI 1640
medium containing 10% fetal bovine serum (FBS) and 1%
antibiotic/antimycotic solution. The cultures were left undisturbed
for a week at 37C with 5% CO2 supplement. The outgrowing
fibroblasts seen after a week from these primary cultures were sub-
cultured immediately using 0.5% Trypsin-EDTA (Invitrogen
Corp.)
Construction of siRNAs and Transfections
Short interfering RNA (siRNA) duplexes were synthesized and
purified by Integrated DNA Technologies (Coralville, IA). The
siRNA sequences targeting rabbit CCT-eta, CCT-beta and
alpha-SMA are shown in Table 1. A ‘‘scrambled’’ siRNA with
an identical base pair composition but randomized sequence was
also obtained as control for both the CCT-eta and CCT-beta
subunits and is also shown in Table 1. A non-specific control
siRNA from Abcam Inc. (Cambridge, MA) was used during a-
SMA siRNA transfection. These siRNAs were employed in adult
fibroblasts in transient transfection experiments wherein a)
fibroblast mobility was assayed in an in vitro wounding protocol,
and b) cellular contractility was assayed through traction force
microscopy.
Rabbit adult fibroblasts were cultured in RPMI 1640
supplemented with 10% fetal bovine serum. Transfection of
siRNAs was performed with the manufacturer’s protocol using
Lipofectamine 2000. Briefly, 7.5 ml of 20 mM siRNA was mixed
with 200 ml of Opti-MEM; 4 ml of Lipofectamine 2000 was diluted
into 200 ml of Opti-MEM and incubated at room temperature for
5 min. After the incubation, the diluted Lipofectamine 2000 was
combined with the diluted siRNAs and then incubated for an
additional 20 min (siRNA sequences targeting both CCT subunits
and a-SMA were used at a concentration of 150 pM). A total of
400 ml of siRNA-Lipofectamine 2000 complexes was added to
each well of cultured rabbit adult fibroblasts at <90% confluence
in a six well plate. After 24 h incubation at 37C the cells were
switched to quiescent media (RPMI 1640 medium containing
0.1% dialyzed FBS along with antibiotics) and left for 48 h. After
48 h of incubation in quiescent media cells were subjected to the in
vitro wounding protocol described below; at this same time, cell
populations were also stimulated either with EGF (1 nM)/ PDGF
(200 nM) or control. Thus, during the period of cell motility
assayed these growth factors (or control, that is, no treatment) were
continuously present. To validate the sequence-specificity of gene
knock-down in vitro, after transfection the fibroblasts were analyzed
for protein and mRNA downregulation by immunoblots and real-
time RT-PCR.
Quantitative Real Time RT-PCR
Total RNA isolated (RNeasy Micro Kit, Qiagen Inc., Valencia,
CA) from rabbit adult fibroblasts after CCT-eta , CCT-beta and
a-SMA siRNA transfection was subjected to real time RT-PCR to
determine the abundance of these two CCT subunit messages.
Primers and probes for these assays were designed by Primer
Express software (Applied Biosystems, Foster City, CA) as
described previously (Satish et al., 2010 manuscript submitted).
The primers were obtained from Integrated DNA Technologies
and the Taqman probes were purchased from Applied Biosystems.
The experimental conditions for RT-PCR were carried out
exactly as described previously [14]. Using the comparative critical
cycle (Ct) method and using GAPDH as the endogenous control,
the expression levels of the target gene products were normalized
and the relative abundance was calculated. Data were analyzed
using the 7900 HT SDS software version 2.1 provided by Applied
Biosystems.
Total RNA extracted from rabbit adult and fetal fibroblasts was
similarly subjected to these quantitative comparative RT-PCR
assays to determine the relative mRNA expression levels of CCT-
eta, CCT-beta and a-SMA in these cell types at baseline.
Immunoblotting
Rabbit adult fibroblasts were lysed using SDS-sample buffer and
proteins were analyzed after siRNA transfection against CCT-eta
and CCT-beta. Proteins from equal volumes of cytosol from the
various experimental conditions were resolved by SDS-PAGE and
analyzed by immunoblotting with antibodies specific for CCT-
eta, CCT-beta, and a-SMA. Antibody against GAPDH was used
as a loading control. Equal amounts of protein lysates isolated
from non-transfected control rabbit adult and fetal fibroblasts were
also subjected to SDS-PAGE and probed with antibodies specific
for CCT-eta, CCT-beta and a-SMA with GAPDH serving as a
loading control.
Cell Migration Assay
Rabbit adult fibroblasts were plated on 6-well plastic dishes and
grown to confluence in RPMI 1640 supplemented with 10% FBS.
The cells were quiesced for 48 h in the media containing 0.1%
Table 1. List of siRNA sequences used to target the genes of
interest.
Gene Sequences
Rabbit CCT-eta Sense-59 rGrArArCrGrArUrUrCrArGrUrArGrUrGrGrCrUTT 39
Antisense-59 rArGrCrCrArCrUrArCrUrGrArArUrCrGrUrUrCTT 39
Rabbit CCT-beta Sense-59rGrGrArGrArArArGrUrUrGrArArCrGrUrArUrUTT-39
Antisense-59rArArUrArCrGrUrUrCrArArCrUrUrUrCrUrCrCTT39
Rabbit a-SMA Sense- 59rArGrArGrArArArUrUrGrUrGrCrUrArUrGrUrCTT39
Antisense-59rGrArCrArUrArGrCrArCrArArUrUrUrCrUrCrUTT39
Scramble Control
CCT-eta
Sense-59rGrArArcrGrArUrUrCrGrArArUrGrCrUrGrGrUTT39
Antisense-59rArCrCrArGrCrArUrUrCrGrArArUrCrGrUrUrCTT39
Scramble Control
CCT-beta
Sense-59rUrGrArArGrArArGrGrArArGrUrUrGrCrUrArUTT39
Antisense-59rArUrArGrCrArArCrUrUrCrCrUrUrCrUrUrCrATT39
doi:10.1371/journal.pone.0010063.t001
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dialyzed FBS; a switch in the media reduces cellular proliferation
and thymidine incorporation over 90% while maintaining cell
viability [33,34]. An in vitro wound healing assay was performed as
previously described [35]. In brief, near confluent cultures of
rabbit adult fibroblasts were scraped making an ,1-cm wide
denuded area, then either stimulated with cytokines {EGF (1 nM)
or PDGF (200 nM)} or with control vehicle only; photographs
were taken at 0 h and 48 h and the relative distance traveled by
the cells at the acellular front was determined by computer-assisted
image analysis. Markings on the plates ensured measurement at
the same site of the photographs at each time point. The distance
migrated was then expressed as a percentage of the control
distance migrated within each experiment, which also facilitated
inter-experiment comparisons.
Measuring Traction of Individual Rabbit Adult Skin-
derived Fibroblasts
Traction, the cellular force that an individual adherent cell
exerts on its substrate, was determined using traction force
microscopy [36]. In this technique, scattered fibroblasts are
plated on a collagen matrix into which are embedded
fluorescently-labelled microbeads. Fibroblast cells attach to the
matrix and, in keeping with their physiology, begin to apply a
traction force to it, resulting in micro-displacements of the
embedded beads. The quantity of displacement is measurable
and can be analyzed through computer-assisted algorithms.
Fibroblast populations treated with multiple agents can be
compared by analyzing a sufficient number of cells from each
experimental condition.
Briefly, a polyacrylamide gel disk (120 mm thick, 10 mm in
diameter) embedded with 0.2 mm green fluorescent micro-beads
(Molecular Probes, Eugene, OR) was made and attached to the
bottom of a 35 mm glass dish (with a 14 mm circular inner glass
area) (MatTek, Ashland, MA) that was consecutively pretreated
with 0.1M sodium hydroxide, 3-aminopropyltrimethoxysilane,
and 0.5% glutaraldehyde. The gel surface was then pretreated
with Sulfo-Sanpah (Pierce, Rockford, IL) and coated with 200 ml
of 100 mg/ml collagen type I.
Rabbit adult and fetal fibroblasts in passage 2–4 were grown in
RPMI-1640 medium containing 10% fetal bovine serum (FBS)
and 1% antibiotic/antimycotic solution as mentioned above.
Initial experiments measured the traction force exerted by adult
fibroblasts relative to that exerted by fetal fibroblasts. We next
investigated the effect of growth factor treatment (using EGF and
PDGF) on adult fibroblast contractility as reflected in the applied
traction force. We then examined whether reduction of CCT-eta
or CCT-beta via siRNA transfection would affect the contractility
of fibroblast cells, either at baseline or in response to growth factor
(PDGF).
For experiments involving siRNA, cells were transfected (as
described above) with CCT-eta and CCT-beta siRNAs and were
also co-transfected with the plasmid pdsRed2-C1 (Clontech
Laboratories, Inc., Mountain View, CA). This vector contains
the red fluorescent protein gene driven by a cytomegalovirus
(CMV) promoter, known to be widely expressed in a variety of cell
types. After 24 h transfection the cells were switched to quiescent
media (RPMI 1640 medium containing 0.1% dialyzed FBS along
with antibiotic/antimycotic solution) and left for another 24 h at
37C. Then, 48 h after transfection, fibroblasts were trypsinized off
their tissue culture vessels and were placed on the above-described
collagen-coated polyacrylamide gel disks at 3000 cells/disk +/2
PDGF (200 nM) and allowed to spread on the collagen surface gel
for 6 h in quiescent medium at 37C. Cells visibly expressing red
fluorescence after this time were selected (at least 5 cells per disk);
these cells are proven to be successfully transfected with pdsRed2-
C1, and are therefore highly likely to have taken up siRNA as well.
This allowed us to collect traction force measurements only from
cells that were likely exhibiting an siRNA mediated downregula-
tion of the CCT-eta/CCT-beta subunits, rather than relying on
capturing a sufficient number of cells by surveying a large group,
which would necessarily include many non-transfected cells. First,
phase contrast images of individual cells as well as red fluorescent
images were taken, followed by imaging of the underlying green
fluorescent beads. Then, the cells on the gel disk were trypsinized
(removing the applied contractile force) and images of the
fluorescent beads at the same view and the same z plane were
taken.
An image correlation method was used to compute the bead
displacement field by comparing the bead image under the
contracting cells with the cell-free bead image. At the beginning of
the image processing, the pair of images was corrected for relative
translational shift. Then the images were divided into small
windows (16 by 16 pixels), and the normalized cross-correlation
function was implemented for each window to find the relative
displacement for each window between these two images. A
hierarchical algorithm, polynomial fitting, and low-pass filtering
was used to minimize the noise level. The traction field was
calculated from the displacement field by using Fourier transform
traction cytometry (FTTC) [36]. The calculation of traction forces
is based on the Boussinesq solution for the displacement field on a
surface of a semi-infinite solid [37]. At least 20 cells in each
experimental group were used to determine their collective
average traction forces.
Statistical Analyses
Statistical analyses were performed by a paired two-tailed
Student’s t-test. A p value of ,0.05 was considered significant.
Results
CCT-eta mRNA and protein levels are reduced in fetal
fibroblasts when compared to adult fibroblasts
We first examined both CCT-eta and CCT-beta message and
protein levels in primary cultures of fetal and adult fibroblasts.
qRT-PCR indicated that CCT-eta mRNA expression was
significantly elevated in adult fibroblasts (by , seven- fold) when
compared to fetal fibroblasts (Figure 1a); in contrast, there was
little difference in CCT-beta messenger abundance between fetal
and adult fibroblasts (Figure 1b). Immunoblotting demonstrated
that CCT-eta protein expression was similarly substantially
elevated in adult fibroblasts compared to fetal fibroblasts, whereas
CCT-beta protein expression showed no difference between the
two cell types (Figures 1c and 1d).
Cell migration of fetal and adult fibroblasts is
differentially modulated by exogenous growth factors
Since one of the main phenotypic attributes of fibroblastic
cells relevant to their role in wound healing and scar formation
is their ability to migrate into a wound bed, we investigated the
migration profiles of fetal and adult fibroblasts in a well-
established in vitro assay [35], both at baseline and in response to
several growth factors known to be important in the adult
wound healing process (EGF and PDGF). Fetal and adult
fibroblasts were noted to have comparable migratory profiles at
baseline, but, as shown in Figure 2, fetal fibroblasts were
completely insensitive to the stimulation of cell migration seen in
adult fibroblasts in response to EGF and PDGF. Whereas adult
fibroblasts significantly increased their migration rates in
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response to several concentrations of these growth factors, fetal
fibroblast migration was unaffected. Although many cellular and
molecular components are involved in cell migration, this
striking observation led us to query whether selective reduction
of the CCT-eta subunit alone might alter the migratory abilities
of adult fibroblasts, in effect rendering them more ‘‘fetal-like’’ in
behavior.
siRNA against CCT-eta and CCT-beta effectively and
specifically downregulates target mRNA and protein in
rabbit adult fibroblasts
We employed siRNA technology to experimentally decrease the
amount of CCT-eta and CCT-beta message (and protein) in
cultures of adult fibroblasts. Cells were transfected either with
experimental siRNAs (against actual target sequence) or with
scrambled control siRNAs (with identical base pair compositions).
After 48 h transfected cells were harvested and analyzed by qRT-
PCR and immunoblotting.
siRNA versus CCT-eta reduced mRNA levels to 29% of control;
this reduction was effective even in the presence of EGF (Figure 3a)
(similar results were obtained with PDGF- data not shown).
Scrambled siRNA sequence had no effect on CCT-eta message.
Neither CCT-beta nor CCT-alpha message levels were affected by
siRNA targeted against CCT-eta (data not shown). Importantly,
CCT-eta siRNA also significantly reduced CCT-eta protein levels as
measured by Western blot (Figure 3c); again, this reduction was
effective even in the presence of added growth factors, and control
scrambled siRNA elicited no such decrease in target protein.
siRNA targeted against CCT-beta was similarly effective,
reducing CCT-beta message by some 50% (by qRT-PCR) and
CCT-beta protein by greater than 50% (by Western blot)
(Figures 3b and 3d). As with CCT-eta, this reduction held even
in the presence of growth factors, and control scrambled siRNA
sequence had no effect on either mRNA or protein levels. CCT-
beta siRNA had no effect on CCT-eta or CCT-alpha message
levels (data not shown).
Figure 1. CCT-eta but not CCT-beta protein and mRNA are differentially expressed in fetal versus adult fibroblasts. RNA and protein
extracted from fetal and adult fibroblasts were subjected to qRT PCR (a & b) and Western blot (c & d) analyses respectively. CCT-eta mRNA was
significantly more abundant in adult fibroblasts when compared to fetal fibroblasts (a); there was no significant difference in CCT-beta message levels
between fetal and adult fibroblasts (b). Values are means 6 SEM of three independent studies performed in duplicate. Statistical analyses were
performed using Student’s t test. NS = non-significant. Equal amounts of protein loaded from fetal and adult fibroblasts showed that adult fibroblasts
express significantly greater CCT-eta protein(c). In contrast CCT-beta protein levels were not different between fetal and adult fibroblasts (d). Blots
shown here are representative of at least three different experiments.
doi:10.1371/journal.pone.0010063.g001
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siRNA against CCT-eta but not CCT-beta inhibits EGF-
and PDGF-induced cell migration in adult fibroblasts
Since we have confirmed that CCT-eta is specifically
decreased during fetal wound healing, and that CCT-beta is
not differentially expressed in either fetal or adult wounds, we
were interested to explore the functional significance of the
specific inhibition of these target genes, CCT-eta and CCT-beta,
on cellular characteristics important to wound healing and scar
formation. We therefore investigated what effect the downreg-
ulation of CCT-eta and CCT-beta by siRNA in adult fibroblasts
would have on their ability to migrate in an in vitro wound
healing assay. Near confluent cultures of adult fibroblasts were
transfected with siRNA versus CCT-eta (or CCT-beta) or
control, then a zone of ‘‘wounding’’ was created by mechanically
removing cells with a rubber policeman. Cultures were then
stimulated with growth factors (or control vehicle only) and
incubated for 48 h while cells moved to repopulate the denuded
‘‘zones of injury.’’ The distance the cells migrated from the
acellular front edge was photographed and measured with
computer assistance, thus arriving at a quantitative value
reflecting cellular motility.
The results of this in vitro wound healing assay, which measures
the averaged and directional migration of a cell population, were
striking and consistent: siRNA-mediated reduction of CCT-eta
markedly decreased basal cell motility to 76%66% (p,0.04)
compared to no treatment and decreased epidermal growth
factor (EGF)-induced cell motility to 108%68% (p,0.01)
compared to EGF treatment alone (144%611%, p,0.02)
(Figure 4a). In contrast downregulation of CCT-beta with siRNA
did not result in any inhibition of either basal cell motility or
EGF-induced cell motility (Figure 4b). In no case did scrambled
siRNA have any effect on cellular migration when compared to
untreated controls.
Virtually identical results were obtained when examining the
effect of CCT subunit downregulation on cell migration in
response to PDGF. Once again downregulation of CCT-eta
inhibited both basal cell motility (70%62%, p,0.009 compared to
no treatment) and PDGF-induced cell migration (to 105%67%,
p,0.01) compared to PDGF treatment alone (151%611%,
p,0.05). As in our experiments with EGF, downregulation of
CCT-beta did not have any effect on either basal or PDGF-
induced cell migration (Figures 5a & 5b).
In each of these experiments we confirmed the successful
donwregulation of CCT-eta (or CCT-beta) mRNA and protein
levels by qRT-PCR and Western blot (as presented in Figure 3)
(data not shown). This evidence strongly supports an important
and specific role for CCT-eta in fibroblast physiology and
reinforces its likely importance to wound healing.
Traction force exerted by adult fibroblasts is higher than
fetal fibroblasts
Having observed that modulation of CCT-eta can affect
fibroblast motility, we also sought to measure its effect on cellular
contractility. Since one of the major differentiating characteristics
of fetal versus adult wound repair is that the latter proceeds
with a contraction of the wound bed, we hypothesized that fetal
fibroblasts may be inherently less contractile than adult. We
therefore first compared the traction forces exerted on their
substrata by fetal fibroblasts versus adult fibroblasts using traction
force microscopy. Under basal conditions adult fibroblasts
apply a significantly stronger traction force (136%629%
p,0.04) to their microenvironment than do fetal fibroblasts
(Figure 6a).
Adult fibroblast contractility is enhanced by stimulation
with growth factors
We next investigated what effect EGF and PDGF have on adult
fibroblast contractility. Cultures of adult fibroblasts were incubated
with these growth factors (or control vehicle) and the ability of
their component cells to exert traction on their substrata was again
quantified by traction force microscopy. Interestingly, although
both agents markedly increased cellular contractility, we found
that PDGF stimulated cellular traction force (201%615%
p,0.03) more highly than EGF (169%69%) (Figure 6b). Since
traction force microscopy is a highly labor intensive assay, this
observation led us to select PDGF as the stimulator to use in
further traction force experimentation.
Figure 2. Cell migration of adult but not fetal fibroblasts is responsive to EGF and PDGF induction. Primary cultures of fibroblasts
obtained from fetal and adult rabbit skin were tested for motility in an in vitro wound healing assay. Cells were treated with increasing concentrations
of EGF (1 nM and 10 nM) and PDGF (40 nM, 100 nM, 200 nM). The values are normalized to baseline motility and shown as EGF- and PDGF-induced
cell motility at each concentration. Fetal and adult fibroblasts had essentially identical baseline motility, but only adult cells responded to growth
factor stimulation. The values are mean 6 SEM of six independent studies each performed in triplicate. Statistical analyses were performed by
Student’s t-test.
doi:10.1371/journal.pone.0010063.g002
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siRNA against CCT-eta but not CCT-beta inhibits PDGF-
induced traction force in adult fibroblasts
We next examined the effect of downregulation of CCT-eta by
siRNA treatment on the cellular contractility of adult fibroblasts.
Cultures of adult fibroblasts were transfected as described above
with CCT-eta/CCT-beta siRNA (or the relevant controls), then
stimulated with PDGF treatment. Cultures were simultaneously
transfected with a marker vector expressing red fluorescent
protein; this allowed us to selectively assay the traction forces of
cells known to have taken up exogenous genetic material,
maximizing the likelihood that such cells had also incorporated
our siRNAs of interest (when present). Our results demonstrate
that CCT-eta siRNA, while having no effect on the contractility of
unstimulated cells, does abrogate the increased traction/contrac-
tility seen with PDGF treatment (108%64%, p,0.01) compared
to PDGF treatment alone (163%63%, p,0.02). In contrast,
CCT-beta siRNA has no effect on either basal cell contractility or
on the PDGF-dependent increase in cellular traction (Figures 7a
and 7b). Scrambled siRNAs had no effect on cellular traction in
any instance. Our data therefore indicate that, in addition to
diminishing the motile response of fibroblast cells, selective
downregulation of CCT-eta can also inhibit their ability to
contract in response to exogenous agents. This reduced potential
contractility may also play a role in discriminating between a fetal
and adult wound healing phenotype.
a-SMA levels are significantly elevated in adult fibroblasts
in comparison to fetal fibroblasts
Since chaperonins are known to mediate the folding of cytoskeletal
actin, as an initial study we determined the mRNA and protein levels
of a-SMA in fetal and adult fibroblasts. We found that both mRNA
and protein levels of a-SMA were significantly higher in adult
fibroblasts when compared to fetal fibroblasts (Figures 8a and 8b).
siRNA against CCT-eta but not CCT-beta markedly
reduces a-SMA protein levels but did not affect beta-
actin levels in adult fibroblasts
We next sought to determine what effect inhibiting CCT-eta
and –beta subunits specifically would have on cellular a-SMA
expression. We found that inhibiting CCT-eta resulted in a
Figure 3. siRNAs against CCT-eta and CCT-beta decrease both basal and EGF- induced mRNA and protein levels of their targets in
fibroblasts. (a & b) qRT-PCR analysis of CCT-eta and CCT-beta mRNA levels showed effective inhibition of both basal expression and EGF-induction
in siRNA-transfected adult fibroblasts. Results are expressed as relative quotient (RQ) of measured CCT-eta or CCT-beta mRNA and were calculated as
a percentage of baseline control levels (100%). Values are means 6 SEM of six independent studies, each performed in duplicate. Statistical analyses
were performed with Student’s t test. Ntx- no transfection; EGF-EGF treatment (1 nM); siRNA-treatment with CCT-eta/CCT-beta siRNA; Scr- treatment
with scrambled control siRNA. (c & d) Western blot results using CCT-eta and CCT-beta antibody (1:500) showed effective reduction of CCT-eta and
CCT-beta protein levels when siRNA was administered but no decrease when scrambled siRNA was employed. GAPDH was used as a loading control.
A representative immunoblot of up to four similar such blots is shown for each analysis.
doi:10.1371/journal.pone.0010063.g003
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dramatic and specific decrease in a-SMA protein but did
not have any effect on cellular beta-actin protein (Figure 9a).
In contrast, CCT-beta inhibition showed no significant
effect on either a-SMA or beta-actin protein accumulation
(Figure 9b).
siRNA against a-SMA effectively and specifically
downregulates target mRNA and protein in rabbit adult
fibroblasts
We next wished to examine the effect of direct downregulation
of a-SMA on basal and EGF-induced cell migration. To this end
Figure 4. siRNA against CCT-eta decreases EGF - induced fibroblast migration, whereas siRNA against CCT-beta does not. Cells were
incubated in the presence or absence of EGF(1 nM) +/2 siRNA against CCT-eta (a) or CCT-beta (b) in an in vitro wound healing assay. In all
experiments a subunit -specific scrambled siRNA sequence was used as control. Cell motility is displayed as a relative percentage of baseline motility
in the absence of EGF or siRNA exposure (100%). Active siRNA versus CCT-eta reduced both basal and EGF-induced motility; siRNA versus CCT-beta
and scrambled controls had no effect. Values are means 6 SEM of six independent studies, each performed in triplicate. Statistical analyses were
performed with Student’s t test.
doi:10.1371/journal.pone.0010063.g004
Figure 5. siRNA against CCT-eta decreases PDGF-induced fibroblast migration, whereas siRNA against CCT-beta does not. Cells were
incubated in the presence or absence of PDGF (200 nM) +/2 siRNA against CCT-eta (a) or CCT-beta (b) in an in vitro wound healing assay. In all
experiments a subunit -specific scrambled siRNA sequence was used as control. Cell motility is shown as a percentage of baseline migration in the
absence of PDGF or siRNA exposure. As with EGF, active siRNA targeting CCT-eta inhibited basal and PDGF-induced motility, whereas CCT-beta siRNA
and scrambled controls did not. Values are means6 SEM of six independent studies, each performed in triplicate. Statistical analyses were performed
with Student’s t test.
doi:10.1371/journal.pone.0010063.g005
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we first synthesized an siRNA specifically targeting rabbit a-SMA.
Adult fibroblasts were transfected either with experimental siRNA
(against actual target sequence) or with a non-specific control
siRNA. After 48 h the transfected cells were harvested and
analyzed by qRT-PCR and immunoblotting.
siRNA versus a-SMA reduced mRNA levels to ,50% of
control; this reduction was effective even in the presence of EGF
(Figure 10a). The non-specific siRNA control had no effect on a-
SMA message. Importantly, a-SMA siRNA also significantly
reduced a-SMA protein levels as measured by Western blot
(Figure 10b); again, this reduction was effective even in the
presence of added growth factor, and non-specific siRNA control
elicited no such decrease in target protein. No effect on cellular
beta-actin was seen with either siRNA construct (data not shown).
Figure 6. Adult fibroblasts are more contractile than fetal fibroblasts. (a) Fetal fibroblasts are less contractile than adult fibroblasts as
determined by traction force microscopy. Each bar represents mean 6 SEM of more than 20 cells from two independent experiments. Statistical
analyses were performed using Student’s t test. (b) PDGF treatment of adult fibroblasts results in an increase in the observed cumulative traction
force; EGF treatment results in a similar although smaller increase. Each bar represents mean 6 SEM of more than 25 cells from two different
experiments. Statistical analyses were performed using Student’s t test.
doi:10.1371/journal.pone.0010063.g006
Figure 7. siRNA against CCT-eta but not CCT-beta reduces PDGF-induced cellular traction force in adult fibroblasts. Adult fibroblasts
transfected with CCT-eta (a) or CCT-beta siRNA (b) along with pDSRed2-C1 were quantified for microdisplacement fields of red fluorescent cells on
the green fluorescent substrate. Each assay was repeated twice with more than 30 cells quantified in each experiment. CCT-eta siRNA abolished the
increased cellular traction force seen with PDGF treatment (200 nM), whereas CCT-beta siRNA and scrambled controls did not. Values are means 6
SEM of two independent experiments with statistical analyses performed using Student’s t test.
doi:10.1371/journal.pone.0010063.g007
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siRNA against a-SMA inhibits both basal and EGF-
induced cell migration in adult fibroblasts
Direct reduction of a-SMA was then accomplished using
siRNA against a-SMA in the setting of our in vitro wound healing
assay to determine what effect this would have on fibroblast
motility. As seen in Figure 11, depletion of a-SMA resulted in
both decreased basal cell motility (86%66% p,0.01 compared
to no treatment) and in an abrogation of the ability of the cell to
respond to the EGF motive stimulus (to 94%64% p,0.001).
Control siRNA had no such effects. These results mirror the
phenotypic changes effected by the specific depletion of the CCT-
eta subunit.
Discussion
Although the scarless wound healing observed in fetal
integumentary tissues has been known for some time, the critical
mechanisms that enable tissue repair to occur absent scar
formation are still unclear. Since fibroblasts are the end effector
cells of scar formation, ultimately such mechanisms must manifest
themselves in fibroblast physiology. This report examines two
parameters of fibroblast physiology critical to wound healing and
scar formation, motility and contractility, and how they are
affected by modulation of the CCT subunits eta and beta.
cDNAs of CCT-eta and –beta from rabbit confirm that these
polypeptides display a significant degree of sequence homology,
Figure 8. mRNA and protein levels show that a-SMA level is significantly increased in adult fibroblasts in comparison to fetal
fibroblasts. RNA and protein extracted from fetal and adult fibroblasts were subjected to qRT PCR (a) and Western blot (b) analyses respectively. The
a-SMA mRNA levels were significantly more abundant in adult fibroblasts when compared to fetal fibroblasts (a). Values are means 6 SEM of three
independent studies performed in duplicate. Statistical analyses were performed using Student’s t test. NS =non-significant. Equal amounts of
protein loaded from fetal and adult fibroblasts showed that adult fibroblasts express significantly greater a-SMA protein (b). GAPDH was used as
loading control.
doi:10.1371/journal.pone.0010063.g008
Figure 9. siRNA downregulation of CCT-eta but not CCT-beta reduces a-SMA protein levels in adult fibroblasts. (a & b)Western blot
showed effective reduction of both CCT-eta and a-SMA protein levels when CCT-eta siRNA was administered, leaving beta-actin largely unaffected. In
contrast, downregulating CCT-beta did not lead to significant reduction in either a-SMA or beta-actin levels. GAPDH was used as loading internal
control. A representative immunoblot of up to three similar such blots are shown for each analysis. Ntx- no transfection; EGF-EGF treatment (1 nM);
siRNA-treatment with CCT-eta/CCT-beta siRNA; Scr- treatment with scrambled control siRNA.
doi:10.1371/journal.pone.0010063.g009
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confirming previous analyses that these subunits (and indeed, all
CCT subunits) likely derive from a common ancestor gene (Satish
et al., submitted). Of the eight subunits that comprise the CCT
holoenzyme, however, only CCT-eta was found to be reduced in
healing fetal wounds, suggesting that it might play a unique role in
the physiology pertinent thereto. Since CCT-beta is the subunit
most closely evolutionarily related to –eta, and since –beta
displayed no evident change in expression in healing fetal (or
adult) wound tissues, we have investigated CCT-beta as the most
appropriate ‘‘control’’ subunit for –eta and its potentially unique
importance to fibroblast behavior.
The reduction of CCT-eta in a healing fetal wound is apparent
as early as 12 hours post-wounding. A wound milieu has multiple
cell types within it, and it is as yet uncertain which manifest the
decrease most, and whether a part of the decrease might result
from migration of cells into or out of the wounded area. In fetal
wounds, this question is less complicated, as there is no significant
infiltration of inflammatory cells, and fibroblasts and epithelial
cells/keratinocytes continue to comprise the main cellular
populations. Our particular interest is in determining the
mechanisms behind scarlessness versus scarring, and the ultimate
end effector cells in this process must be fibroblastic [38], although
of course subject to influence from other cell types. Accordingly,
we based the current study on fibroblasts derived from rabbit fetal
and adult skin and focused on the role of CCT-eta in fibroblast
migration and cellular traction force, two key determinants of the
fibrotic phase of dermal repair. Our own observations with
immunohistochemical analysis of healing fetal and adult wound
tissues indicate that fetal fibroblasts express little CCT-eta in vivo,
whereas adult wound fibroblasts appear to stain more heavily,
consistent with our in vitro results (Satish et al., manuscript in
preparation).
Cell migration plays a vital role in wound healing, tissue
morphogenesis, angiogenesis, and metastasis [39] and has been
previously studied in vitro using a variety of methods, eg., on various
mechanical substrates, 3-D vs. planar migration etc. Using a widely
accepted planar migration assay we first explored whether the
migratory capabilities of fetal and adult fibroblasts differed either at
baseline or in response to growth factors implicated in wound
healing. This question has yielded conflicting answers in previous
studies: some suggest that fetal fibroblasts display enhanced
migratory activity compared to the adult cells [40,41,42] whereas
others do not [43]. It has been reported that serum can both
stimulate [44] and inhibit [45] fetal and adult fibroblast motility;
others find fibroblast migration is entirely independent of serum
factors [39]. Complicating the picture, many investigators use fetal
fibroblast cell lines rather than primary cell cultures [46,47,48].
Our results with low passage primary cultures of fetal and adult
fibroblasts showed no difference in the basal motility of these cells,
but demonstrated a markedly different response to the fibrogenic
growth factors PDGF and EGF. Adult fibroblasts dramatically
increased their migration in response to these agents but fetal
fibroblasts remained insensitive to this stimulus. This distinct
physiology may prove relevant to the differing wound conditions
these cells might be expected to encounter: adult cells would
presumably find it advantageous to migrate rapidly to seal off an
exposed wound site, whereas fetal cells, programmed for function
in the protected uterine environment, may not biologically
recognize any such imperative.
To selectively manipulate CCT subunit levels in our cells of
interest we used siRNAs, which proved effective in reducing the
targeted mRNAs and proteins. The results presented here derive
from the use of single siRNA constructs; we did undertake similar
experiments with multiple siRNAs to attempt to maximize the
Figure 10. siRNA against a-SMA specifically decreases both both basal and EGF- induced mRNA and protein levels of a-SMA in
adult fibroblasts. (a) qRT-PCR analysis of a-SMA mRNA levels showed effective inhibition of both basal expression and EGF-induction in siRNA-
transfected adult fibroblasts. Results are expressed as relative quotient (RQ) of measured a-SMA mRNA and were calculated as a percentage of
baseline control levels (100%). Values are means 6 SEM of six independent studies, each performed in duplicate. Statistical analyses were performed
with Student’s t test. Ntx- no transfection; EGF-EGF treatment (1 nM); siRNA-treatment with a-SMA siRNA; Ctr- treatment with a non-specific control
siRNA. (b) Western blot results using a-SMA antibody (1:500) showed effective reduction of a-SMA protein levels when siRNA was administered but
no decrease when non-specific control siRNA was employed. GAPDH was used as a loading control. A representative immunoblot of up to four
similar such blots is shown for each analysis.
doi:10.1371/journal.pone.0010063.g010
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effects seen, but the results were essentially identical to those with
single constructs alone.
The reduction of CCT-eta with siRNA significantly reduced the
basal and growth factor-induced migration of adult fibroblastic
cells. This observation is in itself striking: although many hundreds
of proteins are certainly involved in the complicated process of
cellular locomotion, reduction of this one protein appears to have
a significant biological effect. No such effect was seen when the
CCT-beta subunit was decreased, suggesting that this may be a
property specific to the eta subunit and distinct from its role as a
component of the CCT holoenzyme. By reducing the adult
fibroblasts’ ability to respond to growth factor induction, it may be
considered that selective downregulation of CCT-eta shifts the
cells’ functional phenotype toward a condition approximating that
of fetal fibroblasts. The results presented here are for EGF and
PDGF, but a similar pattern obtains also for transforming growth
factor-beta, a highly pro-fibrotic agent which can be similarly
counteracted in its effects on fibroblast locomotion by our siRNA
constructs (Satish et al., manuscript in preparation). Thus CCT-
eta may prove an attractive target through which the biological
end effects of multiple scar-promoting growth factors and
cytokines may be blocked concomitantly.
Another cellular characteristic highly pertinent to wound healing
and scar formation is contractility, which we have assayed through
measurement of applied cellular traction force (CTF); this assay
has been found to correlate well with other established methods
such as contraction of fibroblast populated collagen lattices [49].
We note that fetal fibroblasts exert less traction than adult,
consistent with the disparate characteristics of healing fetal versus
adult wounds. We note also that adult fibroblasts become even
more contractile upon treatment with the growth factors EGF and
PDGF, even as they similarly become relatively hypermotile.
Although downregulation of CCT-eta does not appear to have any
effect on cellular basal traction, it does appear to eliminate the
ability of the cells to respond to a growth factor stimulus. The end
result, as with cellular migration, is to shift the fibroblasts’
behavioral profile in a direction more resembling that of fetal
cells. Once again, CCT-beta has no such effect, highlighting again
the distinctive importance of the eta subunit to this characteristic.
Although the above described observations demonstrate a clear
role for CCT-eta in fibroblast physiology, and offer a rationale for
why it is differentially regulated in fetal wounds and cells versus
adult, they do not detail the exact molecular mechanism by which
it acts. This question is a complicated one, since it is difficult to
discriminate between the eta subunit’s known role in the CCT
holoenzyme and its potential functions independent of said
holoenzyme. The CCT chaperonin complex itself stands at the
nexus of a large network as it has been found to interact with a
wide range of proteins implicated in such disparate cellular
processes as endocytosis, mitochondrial function, and even
chromatin remodeling, among others [50]; disruption of the
CCT complex (such as might be accomplished by depletion of any
given subunit) may therefore have pleiotropic effects. Of
immediate apparent relevance is the role of CCT in the synthesis
Figure 11. siRNA against a-SMA inhibits both basal and EGF-induced cell migration in adult fibroblasts. Cells were incubated in the
presence or absence of EGF(1 nM) +/2 siRNA against a-SMA in an in vitro wound healing assay. In all experiments a non-specific control siRNA was
used as a control. Cell motility is displayed as a relative percentage of baseline motility in the absence of EGF or siRNA exposure (100%). Active siRNA
versus a-SMA reduced both basal and EGF-induced motility; a non-specific control siRNA had no such effect. Values are means 6 SEM of eight
independent studies, each performed in duplicate. Statistical analyses were performed with Student’s t test.
doi:10.1371/journal.pone.0010063.g011
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and maturation of actin, a protein essential to both motility and
contractility. However, in vitro biochemical studies of the
interaction between a-SMA and CCT have suggested that the
beta subunit is more directly essential to this dynamic pairing than
eta [51]. Per this previous evidence, then, we might expect to see a
greater effect on a-SMA with CCT-beta siRNA than with CCT-
eta; instead the opposite obtains. In fact, we observe effective
inhibition of a-SMA using CCT-eta siRNA only, whereas cells
treated with CCT-beta siRNA do not show a significant difference
in a-SMA levels. This remarkable observation highlights the
specific importance of the eta subunit to a-SMA expression (and
the cellular characteristics which derive from it).
In fact, both cellular motility and contractility have previously
been well connected to actin expression, and there is also evidence
for a particular role for the a-SMA isoform. Tsai et al. [52] found
that ultrasonic treatment of tendon-derived fibroblasts resulted in
increased a-SMA and a corresponding increase in cell motility.
Conversely, treatment of tendon fibroblasts with glucocorticoids
diminished a-SMA expression with a correlated decrease in cell
motility [53]. Our own findings are in accordance with these results,
with an experimentally-induced specific reduction of a-SMA
resulting in decreased fibroblast motility. Further, adult fibroblasts,
with higher levels of both CCT-eta and a-SMA, were clearly better
able to migrate in response to growth factor stimulation than the
relatively eta- and a-SMA-deficient fetal fibroblasts.
There is a strong case as well for the importance of a-SMA to
fibroblast contractility. Chen et al. [54] examined a-SMA
expression and cellular traction force (CTF) in fibroblasts
stimulated with TGF-b. They found that both a-SMA levels and
CTF increased in a dose-dependent manner. The TGF-b-induced
increase in CTF was reversed by an siRNA specific to a-SMA.
Other agents that inhibited TGF-b-induced a-SMA expression
(eg. basic fibroblast growth factor and a TGF-b type I receptor
inhibitor) also resulted in reduced CTF. These observations were
found to be unrelated to non-muscle myosin II and beta-actin
expression, and clearly implicate a-SMA as an important mediator
of fibroblast/myofibroblast contractility as well as motility.
In this context, and coupled with the previously noted finding
that a-SMA expression correlates with contracting, scar-forming
wounds but is absent from scarlessly healing wounds, our results
build upon a growing body of evidence that fibroblast motility and
contractility are important determinative features of wound
contraction and scar formation, and that a critical element in
this process is a-SMA. Since CCT-eta is shown herein to be
essential for a-SMA protein accumulation, we posit that reduction
of CCT-eta regulates fibroblast motility and contractility through
its downstream reduction of a-SMA. The reduction of CCT-eta
seen in fetal wound tissues, reflected also in the relative paucity of
CCT-eta in fetal fibroblasts, may therefore be a crucial component
of the scarless nature of fetal wound repair.
Although our findings demonstrate the specific importance of
the CCT-eta subunit to fibroblast biology and define its effect on
a-SMA, the question of whether this effect is through perturbation
of CCT holoenzyme function or is a CCT-independent phenom-
enon remains unsettled. Since reduction of CCT-beta had no
effect on fibroblast motility and contractility (but would be
expected to disturb CCT holoenzyme function in a manner
similar to CCT-eta depletion), it remains possible and perhaps
even likely that our observations derive from a CCT-eta
monomer-specific function.
CCT-eta has been shown to have a specific biologic activity
separate from its role in the greater CCT complex: CCT-eta was
recently found to be a co-factor for the soluble guanylyl cyclase
(sGC), the chief intracellular secondary mediator of nitric oxide
(NO) signaling [26]. Eta acts as an inhibitor of sGC; the net result
of a downregulation of eta, therefore, would be a relative increase
in sGC activity, resulting in increased cGMP and amounting to an
increased functional NO signal. NO has previously been found to
inhibit the PDGF-induced migration of fibroblasts and pericytes
[55] and to inhibit the trans-endothelial migration of T cells [56],
but likely acts in cell specific fashion through a variety of
downstream molecular mediators. Although NO has been well
studied in adult wound healing and is thought to favorably affect
wound healing in general [57,58,59], its role in fibroblast
physiology and especially in fetal wound repair is still relatively
unexplored. The interaction of CCT-eta with sGC may represent
one molecular mechanism which can (under certain circumstanc-
es) recapitulate an NO-dependent physiology.
Surprisingly, our results show that downregulating CCT-eta
actually decreased cGMP levels in adult fibroblasts (data not
shown). Since steady state cGMP levels are obviously the product
of countervailing synthetic and degradative processes, it remains
possible that decreasing CCT-eta is allowing for actual increased
cGMP production but that this is overwhelmed by other
downstream factors. On balance, however, with reduced cGMP
levels it seems unlikely that the effects we observe by inhibiting
CCT-eta on fibroblast contractility and motility are operating
through a process that recapitulates nitric oxide signaling. Of
course, both contractility and motility are extremely complex
properties that result from the summation of numerous factors
within cells; more experimentation will be required to further
elucidate which other specific interactions may contribute
particularly to fibroblast behavior and to the different properties
of fetal versus adult cells.
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